𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PARP-1 modulates deferoxamine-induced HIF-1α accumulation through the regulation of nitric oxide and oxidative stress

✍ Scribed by Rubén Martínez-Romero; Esther Martínez-Lara; Rocío Aguilar-Quesada; Andreína Peralta; F. Javier Oliver; Eva Siles


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
413 KB
Volume
104
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Poly(ADP‐ribose) polymerase‐1 (PARP‐1) is a nuclear protein that, once activated by genotoxic agents, modulates the activity of several nuclear proteins including itself. Previous studies have established that PARP‐1 inhibition may provide benefit in the treatment of different diseases, particularly those involving a hypoxic situation, in which an increased oxidative and nitrosative stress occurs. One of the most important transcription factors involved in the response to the hypoxic situation is the hypoxia‐inducible factor‐1 (HIF‐1). The activity of HIF‐1 is determined by the accumulation of its α subunit which is regulated, in part, by oxidative stress (ROS) and nitric oxide (NO), both of them highly dependent on PARP‐1. Besides, HIF‐1α can be induced by iron chelators such as deferoxamine (DFO). In this sense, the therapeutical use of DFO to strengthen the post‐hypoxic response has recently been proposed. Taking into account the increasing interest and potential clinical applications of PARP inhibition and DFO treatment, we have evaluated the impact of PARP‐1 on HIF‐1α accumulation induced by treatment with DFO. Our results show that, in DFO treated cells, PARP‐1 gene deletion or inhibition decreases HIF‐1α accumulation. This lower HIF‐1α stabilization is parallel to a decreased inducible NO synthase induction and NO production, a higher response of some antioxidant enzymes (particularly glutathione peroxidase and glutathione reductase) and a lower ROS level. Taken together, these results suggest that the absence of PARP‐1 modulates HIF‐1 accumulation by reducing both NO and oxidative stress. J. Cell. Biochem. 104: 2248–2260, 2008. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Inverse regulation of inducible nitric o
✍ Kathryn L. Bonaparte; Chad A. Hudson; Charlene Wu; Paul T. Massa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 1 views

We have previously shown that the SH2 domain-containing protein tyrosine phosphatase SHP-1 plays a critical role in controlling virus infection in CNS glia in vivo and in vitro. The present study addressed whether increased virus replication in SHP-1-deficient glia in vitro may be a result of altere

Differential regulation of cyclooxygenas
✍ France Vaillancourt; Barbara Morquette; Qin Shi; Hassan Fahmi; Patrick Lavigne; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

## Abstract 4‐hydroxynonenal (HNE), a lipid peroxidation end product, is produced abundantly in osteoarthritic (OA) articular tissues and was recently identified as a potent catabolic factor in OA cartilage. In this study, we provide additional evidence that HNE acts as an inflammatory mediator by

Treatment of experimentally induced tran
✍ Dr. Mason C.P. Leung; Samuel C.L. Lo; Flora K.W. Siu; K.-F. So 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## Background and Objectives Nitric oxide (NO) has been shown to be neurotoxic while transforming growth factor‐beta 1 (TGF‐β1) is neuroprotective in the stroke model. The present study investigates the effects of low energy laser on nitric oxide synthase (NOS) and TGF‐β1 activities af